Angiotension II Receptor Blocker. Index Background - RAS(Renin-Angiotensin System) Angiotensin II Receptor Blocker(Sartan compound) Introduction Chemistry.

Slides:



Advertisements
Similar presentations
Low Blood Pressure Feedback Loop
Advertisements

DMAT PA-1 PHARMACY CACHE CARDIOVASCULAR AGENTS Saundra Martino, RpH.
Tina Stutzman Nick Swenson May 12, 2010
BACK TO BASICS: PHARMACOLOGY CHAD C. CRIPE, MD Department of Anesthesiology & Critical Care Medicine Division of Cardiothoracic Anesthesiology The Children’s.
Integrative Physiology II: Fluid and Electrolyte Balance
The Physiology of the Afferent and Efferent Arterioles
ACE Inhibitors ACE = Angiotensin I Converting Enzyme 10 ACE inhibitors available in US:  benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril,
Angiotensin converting enzyme (ACE) ACE is a zinc-containing dipeptidyl carboxypeptidase, which converts angiotensin I to angiotensin II AngiotensinAngiotensin.
Hormone Regulation of Urine Formation
The Renin-Angiotensin- Aldosterone System MATT VREUGDE
Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 9 th Lecture.
SL MD4 Enzyme inhibitors as medicines. A bit like the antagonists! Noradrenaline (neurotransmitter) Fits into receptor site Electrical impulse sent to.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Antihypertensives Chad Byworth. Hypertension What is hypertension? Blood pressure of greater than 140 systolic or 90 diastolic, confirmed in primary care.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
Anti-hypertensive agents
Losartan: An Attempt at Fighting Heart Failure By: Jennifer DeLaet Biochemistry/Molecular Biology Seminar University of Wisconsin-Eau Claire March 29,
Drugs Acting on the Renin-Angiotensin-Aldosterone System
CARDIOVASCULAR DISEASE 1.HYPERTENSION 2.ISCHAEMIC HEART DISEASE 3.THROMBO-EMBOLIC DISEASE Myocardial infarction Stroke Medical Pharmacolgy & Therapeutics.
 Hypertension : BPDIASTOLIC SYSTOLIC Normal< 130< 85 Mild hypertension Moderate hypertension Severe Hypertension 180.
Renin-Angiotensin-Aldosterone System Juxtaglomerular apparatus secretes renin. Juxtaglomerular apparatus secretes renin. Renin acts on angiotensinogen.
Connect! Do you know of anyone who has to take thyroid medicine? Why? What causes gigantism? Do you know of anyone who is a diabetic? What causes it?
A proposal for: High affinity RNA aptamers as antagonists for AT 2 receptors Tina Stutzman Nick Swenson May 12, 2010.
1 Drug Treatment of heart failure. Prof. Azza El-Medani Prof. Abdulrahman Almotrefi.
Renin-Angiotensin System Drugs Igor Spigelman, Ph.D. Division of Oral Biology & Medicine, UCLA School of Dentistry, CA Rm CHS
1 Drug Therapy of heart failure. Prof. Azza El-Medani Prof. Abdulrahman Almotrefi.
The Renin-Angiotensin System
Vasoactive peptides By S.Bohlooli, PhD. Vasoactive peptides Vasoconstrictors: Angiotensin II Vasopressin Endothelins Neuropeptide Y urotensin Vasodilators:
Human Endocrine Physiology May 8, Lungs Actions of AII and Aldosterone Angiotensin II Stimulates aldosterone secretion Causes vasoconstriction.
Cardiovascular drugs By Dr. fatmah alomary
ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN TYPE I DIABETIC NEPHROPATHY DR.NASIM MUSA.
Angiotensin Converting Enzyme inhibitor (ACEI) Vilasinee Hirunpanich B. Pharm(Hon), M.Sc in Pharm(Pharmacology)
بسم الله الرحمن الرحيم.
CVS PHARMACOLOGY. Drugs to treat myocardial ischemia Etiology 1. Decrease in myocardial oxygen supply [determined by oxygen-carrying capacity of blood.
PEPTIDES. Tissue damage, allergic reactions, viral infections and other inflammatory events activate a series of proteolytic rections that generate BK.
Prodrugs.
Pharmacology of Renin-Angiotensin system
Effect of some adrenergic drugs and its blockers on the blood pressure.
HYPERTENSION SUMMIT. Hypertension Epidemiology Prevalence of Hypertension worldwide: – 1 Billion Deaths worldwide: – 7 million per year In USA, 90% lifetime.
Conivaptan -vaptan = Vasopressin receptor antagonist.
Bioisosteres Hiroyuki Kobayashi Jan
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Path to an Angiotensin Receptor Antagonist-Neprilysin.
Blood Pressure.
Blood pressure (BP) A constant flow of blood is necessary to transport oxygen to the cells of the body The arteries maintain an average blood pressure.
Losartan: An Attempt at Fighting Heart Failure
Professor Dr. Imad A-J Thanoon
ANTI-HYERTENSIVE DRUGS: Therapeutic overview
Diagram representing the renin–angiotensin–aldosterone system
AT1 receptor blockade can result in the stimulation of the AT2 receptor. Figure 6. AT1 receptor blockade can result in the stimulation of the.
Native ace enzyme Angiotensin-converting enzyme (EC ), or "ACE" indirectly increases blood pressure by causing blood vessels to constrict. It does.
THE SILENT KILLER HYPERTENSION.
Isolated Systolic Hypertension: An Update After SPRINT
Losartan: An Attempt at Fighting Heart Failure
Ecosanoids Prostaglandins. Thromboxanes. Leukotrienes.
Induction of Type 2 Diabetes Mellitus with Antihypertensive Therapy: Is There Any Role of Alpha Adducin, ACE, and IRS-1 Gene?  Sumeet Gupta, MPharm, PhD,
Losartan: An Attempt at Fighting Heart Failure
Viper venom for diabetic nephropathy
Frederic Rahbari-Oskoui, MD, MS  American Journal of Kidney Diseases 
Volume 12, Issue 5, Pages (November 2010)
Orly Vardeny et al. JCHF 2014;2:
Viper venom for diabetic nephropathy
Drugs Acting on the Renin-Angiotensin-Aldosterone System
Antihypertensive Drugs
Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016  Murray Epstein, MD, Daniel A. Duprez,
ORGANIC PHARMACEUTICAL CHEMISTRY IV
Isolated Systolic Hypertension: An Update After SPRINT
Sympathomimetics or Adrenergic Drugs
Volume 68, Issue 5, Pages (November 2005)
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications 
Schematic of the interaction between the renin-angiotensin-aldosterone system (RAAS) system and the natriuretic peptides and how the RAAS modulators and.
Presentation transcript:

Angiotension II Receptor Blocker

Index Background - RAS(Renin-Angiotensin System) Angiotensin II Receptor Blocker(Sartan compound) Introduction Chemistry Assay data

Hypertension 혈관 수축에 의한 고혈압 Angiotension II 에 의한 혈관수축 혈관 내에 혈류량에 의한 고혈압 Aldosterone 에 의한 이온 재흡수 및 물의 잔류

Angiotensin? Octapeptide Produced by RAS Key role in the Pathophtsiology of hypertension. Vasoactive hormone. Regulate the cardiovascular homeostasis by acting on both the vascular resistance and the blood volume.

RAS(Renin-Angiotensin System)

Angiotensin II Receptor Blocker (Sartan compound)

Tetrazole included sartan compound Valsartan Losartan Candesartan Fimasartan OlmesartanIrbesartan

Angiotensin II Receptor Blocker (Sartan compound) Other form sartan compound(Imidazole included) EprosartanTelmisartanAzilsartan

Angiotensin II Receptor Blocker (Sartan compound)

Introduction Angiotensin II is an octapeptide produced by the renin- angiotensin system, which plays a key role in the pathophysiology of hypertension. AngII is produced in vivo from angiotensin I by the angiotensin converting enzyme(ACE) EX) Enalapril, Captopril. This ACE is not a very selective enzymes. EnalaprilCaptopril

Introduction Thus the specific block of Ang II actions at the receptor level represents a potentially convenient approach to modulate the RAS. The parallel discovery of losartan and eprosartan, potent and orally active nonpeptide Ang II antagonists. Most of these compounds have the biphenyl fragment bearing an acidic moiety(tetrazole ring, COOH, SO2NHCO) in common and differ in the nature of the pendent heterocyclic system (valasartan lakcs the heterocyclic moiety) connected to the para position of the distal phenyl by means of a methylene group.

Introduction

A>Effects of the modification of the distal phenyl ring

B>Effects of the modification of the acidic moiety

C>Effects of the introduction of a substituent in the ortho position with respect to the acidic moiety

D>Effects of the modification of the lipophilic substituent in position 2 of the imidazo[4,5-b]- pyridine nucleus.

Summuary Losartan 의 유사체를 만들어 Angiotensin 2 receptor blocker 로서 역할을 하는 물질을 합성하 였다. Biphenyl system 에 amine 기를 도입했을때 2f 물질 이 그나마 약효가 있는것을 발견해서 새로운 타 겟으로 설정하였다. 4b 는 2f 와 비슷한 약효를 보였고 Loasartan 과도 유사한 약효가 보였다. Binding mode 를 살펴서 물질과 receptor 간의 binding site 를 살펴보았다.